Proton magnetic resonance spectroscopy with dementia.

To provide new insights into metabolic changes in the brain of patients with dementia, we performed in vivo localized proton magnetic resonance spectroscopy in nine patients with primary degenerative dementia and in three patients with normal-pressure hydrocephalus. We compared the results with those in 26 healthy volunteers. Measurements of regional cerebral blood flow were performed in seven patients by means of single photon emission computed tomography with amphetamine I 123 as a tracer. The magnetic resonance spectra constantly showed three major peaks corresponding to N-acetylaspartate (NAA), creatine and phosphocreatine (Cr), and choline-containing compounds. There were no age-related changes in the mean area ratio of NAA to Cr in neurologically normal volunteers. The NAA/Cr ratio was significantly reduced in patients with primary degenerative dementia. The reduction of the NAA/Cr ratio was observed even in dementia patients with no significant brain atrophy or reduction in regional cerebral blood flow. No significant reduction of the NAA/Cr ratio was seen in patients with normal-pressure hydrocephalus. The NAA/Cr ratio might reflect the number and/or activity of neuronal cells in the brain. Proton magnetic resonance spectroscopy may well provide a useful tool for early detection of, and further pathophysiological study of, primary degenerative dementia.

[1]  Jimmy D Bell,et al.  Proton MR spectroscopy in herpes simplex encephalitis: assessment of neuronal loss. , 1990, Journal of computer assisted tomography.

[2]  J. Coyle,et al.  The neurobiology of N-acetylaspartylglutamate. , 1988, International review of neurobiology.

[3]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[4]  P. Colletti,et al.  Quantitative magnetic resonance imaging and the severity of dementia in Alzheimer's disease. , 1988, The American journal of psychiatry.

[5]  P F Sharp,et al.  Multimodal Imaging in Alzheimer's Disease , 1990, British Journal of Psychiatry.

[6]  J. Coyle,et al.  Seizures decrease regional enzymatic hydrolysis of N-acetyl-aspartylglutamate in rat brain , 1989, Brain Research.

[7]  D. Menon,et al.  Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. , 1990, Journal of computer assisted tomography.

[8]  B C Bowen,et al.  MR signal abnormalities in memory disorder and dementia. , 1990, AJNR. American journal of neuroradiology.

[9]  J. Coyle,et al.  N‐Acetyl‐Aspartyl‐Glutamate: Regional Levels in Rat Brain and the Effects of Brain Lesions as Determined by a New HPLC Method , 1984, Journal of neurochemistry.

[10]  B. Holman,et al.  Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123. , 1987, Archives of neurology.

[11]  A. Brancati,et al.  Distribution of N-acetylaspartate, N-acetylaspartylglutamate, free glutamate and aspartate following complete mesencephalic transection in rat neuraxis , 1990, Neuroscience Letters.

[12]  J. Frahm,et al.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.

[13]  S. Gauthier,et al.  Antemortem laboratory diagnosis of Alzheimer's disease , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[14]  Der,et al.  Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. , 1990, Radiology.

[15]  P. Hecke,et al.  Human brain proton localized NMR spectroscopy in multiple sclerosis , 1991, Magnetic resonance in medicine.

[16]  J. Coyle,et al.  Dipeptides of glutamate and aspartate may be endogenous neuroexcitants in the rat hippocampal slice , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  A. Alavi,et al.  Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  P. Narayana,et al.  Serial proton magnetic resonance spectroscopy of ischemic brain injury in humans. , 1990, Investigative radiology.

[19]  J. Coyle,et al.  N-acetylaspartylglutamate: an endogenous peptide with high affinity for a brain "glutamate" receptor. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Coyle,et al.  N-Acetylaspartylglutamate: possible role as the neurotransmitter of the lateral olfactory tract. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Y. Kakimoto,et al.  A Gas Chromatographic Method for the Determination of N‐Acetyl‐l‐Aspartic Acid, N‐Acetyl‐α‐ Aspartylglutamic Acid and β‐Citryl‐l‐Glutamic Acid and Their Distributions in the Brain and Other Organs of Various Species of Animals , 1981, Journal of neurochemistry.

[22]  R Harrop,et al.  Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease , 1986, Neurology.

[23]  J. Mori-Okamoto,et al.  Electrophysiological and pharmacological actions of N-acetylaspartylglutamate intracellularly studied in cultured chick cerebellar neurons , 1987, Brain Research.

[24]  A. Kertesz,et al.  Cognition and white matter changes on magnetic resonance imaging in dementia. , 1990, Archives of neurology.

[25]  J. Frahm,et al.  Cerebral metabolism in man after acute stroke: New observations using localized proton NMR spectroscopy , 1989, Magnetic resonance in medicine.

[26]  J. Coyle,et al.  The Journal of Histochemistry and Cytochemistry Production and Characterization of Monoclonal Antibodies to N-acetyl-aspartyl-glutamate' , 2022 .

[27]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[28]  P. Colletti,et al.  Magnetic resonance imaging and the severity of dementia in older adults. , 1990, Archives of general psychiatry.

[29]  F. Smith,et al.  Nuclear Magnetic Resonance (NMR) II. Imaging in Dementia , 1985, British Journal of Psychiatry.

[30]  M. Cuénod,et al.  Release of N‐Acetylaspartylglutamate on Depolarization of Rat Brain Slices , 1988, Journal of neurochemistry.

[31]  J. Glowinski,et al.  Depolarization-evoked release of N-acetyl-L-aspartyl-L-glutamate from rat brain synaptosomes. , 1988, European journal of pharmacology.

[32]  M. Mayer,et al.  High concentrations of N-acetylaspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[33]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[34]  Richard H. Griffey,et al.  VAPOR for solvent-suppressed, short-echo, volume-localized proton spectroscopy , 1990 .

[35]  D. Loewenstein,et al.  Sensitivity and specificity of positron emission tomography and magnetic resonance imaging studies in Alzheimer's disease and multi-infarct dementia. , 1989, European neurology.

[36]  J. Coyle,et al.  Ontogenesis of N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in rat brain. , 1984, Brain research.

[37]  P Gerundini,et al.  Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  J. Coyle,et al.  Calcium‐Dependent Evoked Release of N[3H]Acetylaspartylglutamate from the Optic Pathway , 1988, Journal of neurochemistry.

[39]  M Brant-Zawadzki,et al.  MR imaging of the aging brain: patchy white-matter lesions and dementia. , 1985, AJNR. American journal of neuroradiology.

[40]  P. Sharp,et al.  Application of iodine-123-labeled isopropylamphetamine imaging to the study of dementia. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[41]  C R Jack,et al.  MR findings in normal-pressure hydrocephalus: significance and comparison with other forms of dementia. , 1987, Journal of computer assisted tomography.

[42]  E. R. Kloet,et al.  N-acetyl-aspartylglutamate: binding sites and excitatory action in the dorsolateral septum of rats , 1987, Brain Research.